CEO increases direct stake by 1,773.05%
Pulse Biosciences CEO Paul A. LaViolette purchased 15,000 company shares on May 11, 2026, at $19.69 per share.
The acquisition increased his direct ownership from 846 to 15,846 shares, representing a significant increase in his stake.
The current stock price is $24.55 as of May 15, 2026, reflecting a 24.7% gain from the purchase price over four days.